Status:
COMPLETED
To Compare TEG (Thrombelastography) and Conventional Tests in CKD Patients
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
End Stage Renal Disease
Coagulopathy
Eligibility:
All Genders
18+ years
Brief Summary
Background: Coagulopathy in chronic kidney disease is multifactorial. Both hypocoagulopathy and hypercoaguability are seen. Conventional tests of coagulation (CCTs) end at the formation of thrombin, a...
Eligibility Criteria
Inclusion
- Healthy voluntary donors belonging to ASA PSI or ASA PSII
- Patients suffering from end stage renal disease i.e. CKD stage 5 (Defined by KDIGO 2012 ) who never received renal replacement therapy (RRT)
Exclusion
- Patients on antiplatelet drugs, erythropoietin, desmopressin
- Patients with known bleeding disorders like haemophilia, aplastic anaemia etc
- Patients having coexisting liver diseases
- Patients on dialysis
- Patients who have received PRBC, FFPs or Platelet Transfusions in the past 3 months
- Patients less than 18 years of age
- Pregnant patients
- Malignancy
Key Trial Info
Start Date :
March 12 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 22 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03275077
Start Date
March 12 2016
End Date
December 22 2016
Last Update
June 12 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.